- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da innoVactiv Inc
Totale 35939 risultati
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletatoTubercolosi, PolmonareBielorussia, Georgia, India, Sud Africa
-
Gruppo Italiano Terapie Innovative nei LinfomiCompletatoLinfoma diffuso a grandi cellule BItalia
-
French Innovative Leukemia OrganisationCelgene CorporationCompletatoLeucemia mieloide acutaFrancia
-
University Hospital, LilleInnovative Medicines InitiativeCompletatoMalattia di Alzheimer | BatteriaFrancia
-
Foundation for Innovative New Diagnostics, SwitzerlandReclutamento
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletatoInfezione respiratoria da COVID-19Svizzera, Uganda, Regno Unito
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletatoTubercolosi, multiresistente ai farmaciGeorgia, India, Sud Africa
-
French Innovative Leukemia OrganisationJanssen, LPAttivo, non reclutanteLeucemia linfocitica cronica recidivante o refrattariaFrancia
-
Center for Innovative Public Health ResearchSconosciuto
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletatoInfezione del flusso sanguignoBotswana
-
Foundation for Innovative New Diagnostics, SwitzerlandCompletato
-
French Innovative Leukemia OrganisationNovartis PharmaceuticalsCompletatoAntiriciclaggioFrancia
-
Complexa, Inc.Medpace, Inc.; Allegheny Singer Research Institute (also known as Allegheny Health... e altri collaboratoriTerminato
-
IND Diagnostic Inc.Sconosciuto
-
Sciema UGInnovative Diabetes Treatment Studies LLC.CompletatoDiabete mellito, tipo 2 | Diabete mellito, tipo 1Stati Uniti, Germania
-
Sciema UGInnovative Diabetes Treatment Studies LLC.Attivo, non reclutanteDiabete mellito, tipo 2Germania, Stati Uniti
-
Zhejiang UniversityInnovative Cellular Therapeutics Co., Ltd.Sconosciuto
-
University of SurreyGlaxoSmithKline; Innovative Medicines InitiativeCompletato
-
French Innovative Leukemia OrganisationHoffmann-La RocheCompletatoLinfoma a cellule del mantelloFrancia
-
Innovative Humanitarian SolutionsUniversity of Houston - VictoriaSconosciuto
-
Innovative Cardiovascular SolutionsYale Cardiovascular Research GroupReclutamentoStenosi della valvola aortica | Malattia della valvola aortica | Insufficienza della valvola aortica | Sostituzione della valvola aorticaStati Uniti
-
PfizerInnovative Medicines Initiative (IMI) COMBACTE-CARECompletatoInfezioni intraddominali complicate, cIAISpagna, Francia, Germania
-
French Innovative Leukemia OrganisationRoche Pharma AGCompletatoLeucemia linfocitica cronica a cellule B LLCFrancia
-
University Hospital, AngersFrench Innovative Leukemia OrganisationSconosciutoLeucemia linfoblastica acuta dell'adultoFrancia
-
French Innovative Leukemia OrganisationHoffmann-La RocheReclutamento
-
French Innovative Leukemia OrganisationUniversity Hospital, LilleReclutamentoLeucemia prolinfocitica | Leucemia a cellule TFrancia
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletatoPiccola leucemia linfocitica | LLC, recidivato | CLL, Refrattario | Inibitore della tirosin-chinasi BrutonFrancia
-
University Hospital, ToulouseFrench Innovative Leukemia OrganisationCompletatoLeucemia mieloide acutaFrancia
-
Foundation for Innovative New Diagnostics, SwitzerlandUNITAIDCompletatoEpatite C, cronicaAustralia, Camerun, Georgia, Grecia, Ruanda
-
French Innovative Leukemia OrganisationLymphoma Study AssociationCompletatoLinfoma a cellule del mantelloFrancia
-
French Innovative Leukemia OrganisationMundipharma Pte Ltd.CompletatoLinfoma a cellule TFrancia
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationCompletatoLinfoma a cellule T perifericheFrancia
-
French Innovative Leukemia OrganisationNovartis; Schering SACompletatoGOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the ElderlyLeucemia mieloide acutaFrancia
-
German Centre for Assessment and Evaluation of...Non ancora reclutamentoComplicazione | Continenza | Potenza | Recidiva biochimicaGermania
-
St. Jude Children's Research HospitalEisai Inc.; Medicines for Malaria Venture; Global Health Innovative Technology...Completato
-
Innovative Chemical and Environmental Technologies...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatoInfezione del tratto urinarioStati Uniti
-
University of OxfordInnovative Medicines Initiative; Respiratory syncytial virus consortium in EuropeAttivo, non reclutanteVirus respiratorio sinciziale (RSV)Regno Unito
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationNon ancora reclutamento
-
Children's Hospital of Orange CountyInnovative Health SolutionsReclutamentoCOVID-19 | Sindrome post-concussione | COVID a lungo raggioStati Uniti
-
University of California, Los AngelesInnovative Health SolutionsReclutamentoSindrome dell'intestino irritabile | Dolore addominale | Squilibrio del sistema nervoso autonomoStati Uniti
-
Foundation for Innovative New Diagnostics, SwitzerlandAustralian GovernmentCompletatoMalaria | Diagnostica la malattia | RDTRuanda
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationCompletatoLMA adulta recidivante | LMA refrattaria | Mutazione FLT3-TKD | FLT3-ITDFrancia
-
French Innovative Leukemia OrganisationAbbVie; Janssen-Cilag Ltd.Attivo, non reclutanteLeucemia linfocitica cronica a rischio intermedio | Pazienti in forma | Strategia adattata al rischio e guidata dalla MRDFrancia
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationNon ancora reclutamento
-
Universitaire Ziekenhuizen KU LeuvenInnovative Medicines Initiative; BELpREGReclutamentoAllattamento al seno | Latte UmanoBelgio
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationReclutamentoLMA, adulto | LMA adulta recidivante | LMA refrattaria | Mutazione FLT3-TKD | FLT3-ITDFrancia
-
Morris Innovative IncorporatedDeborah Heart and Lung CenterSconosciutoMalattie vascolariStati Uniti
-
French Innovative Leukemia OrganisationSconosciuto
-
French Innovative Leukemia OrganisationSconosciuto
-
University Hospital, GrenobleFrench Innovative Leukemia Organisation; BGMTCompletato